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ABSTRACT
Estrogen and mechanical forces are positive regulators for osteoblast proliferation and bone formation. We investigated the synergistic
effect of estrogen and flow-induced shear stress on signal transduction and gene expression in human osetoblast-like MG63 cells and
primary osteoblasts (HOBs) using activations of extracellular signal-regulated kinase (ERK) and p38 mitogen-activated protein kinase
(MAPK) and expressions of c-fos and cyclooxygenase-2 (I) as readouts. Estrogen (17b-estradiol, 10nM) and shear stress (12 dyn/cm
2)
alone induced transient phosphorylations of ERK and p38 MAPK in MG63 cells. Pretreating MG63 cells with 17b-estradiol for 6 hours
before shearing augmented these shear-induced MAPK phosphorylations. Western blot and flow cytometric analyses showed that
treatingMG63cellswith17b-estradiolfor6hrsinducedtheirb1-integrinexpression.Thisestrogen-induction ofb1-integrinwasinhibited
by pretreating the cells with a specific antagonist of estrogen receptor ICI 182,780. Both 17b-estradiol and shear stress alone induced c-
fosandCox-2geneexpressions inMG63 cells.PretreatingMG63cellswith17b-estradiolfor6hrsaugmentedthe shear-inducedc-fosand
Cox-2 expressions. The augmented effects of 17b-estradiol on shear-induced MAPK phosphorylations and c-fos and Cox-2 expressions
were inhibited by pretreating the cells with ICI 182,780 or transfecting the cells with b1-specific small interfering RNA. Similar results on
the augmented effect of estrogen on shear-induced signaling and gene expression were obtained with HOBs. Our findings provide
insights into the mechanism by which estrogen augments shear stress responsiveness of signal transduction and gene expression in
bone cells via estrogen receptor–mediated increases in b1-integrin expression.  2010 American Society for Bone and Mineral Research.
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Introduction
M
echanical loading is essential for maintaining skeletal
integrity and bone mass.
(1) Suppression of this stimulus
under conditions such as long-term bed rest and space flight
results in bone loss and even osteoporosis.
(2) During dynamic
loading of intact bone, interstitial fluid (ISF) flow through the
canaliculi generates shear stress that is detected by bone cells,
including osteoblasts.
(3) It has been shown that fluid shear stress
regulates signaling, gene expression, proliferation, and differ-
entiation in osteoblasts.
(4) Recent studies using flow channels
demonstrated that application of fluid shear stress to osteoblasts
induces their expression of many genes, including transcription
factor c-fos
5 and cyclooxygenase-2 (Cox-2),
(5) both of which have
beenshowntoplayimportantrolesinboneformationinvivo.
(6,7)
In addition to mechanical forces, estrogen, a major sex steroid
hormone in female, has been shown to induce osteoblast
proliferation and bone formation, with suppression in bone
tissue resorption by decreasing osteoclast activity.
(8) A deficiency
of estrogen accelerates bone lose; this is probably the major
reason leading to osteoporosis in menopausal women.
(9) 17b-
Estradiol represents a major estrogen in human, and it is
produced by granulose cells of the ovary, with small amounts
also being produced by the adrenal cortex. Recent studies
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627showed that 17b-estradiol induces insulin-like growth factor 1
(IGF-1) and alkaline phosphatase (ALP) production through
estrogen receptors (ERs) to increase osteoblast proliferation and
bone formation.
(10,11) Blockage of ERs by the specific ER
antagonist ICI 182,780 inhibited 17b-estradiol-induced IGF-1
and ALP productions by osteoblasts.
(10,11) In addition, estrogen
has been shown to inhibit osteoblast and osteocyte apoptosis
and promote the survival of these cells, which contributes to the
beneficial effect of the steroids in bone.
(12–14) Although both
estrogen and mechanical force have been shown to be positive
regulators for osteoblast proliferation and bone formation,
whether they play synergistic roles in modulating signaling and
gene expression in osteoblasts remains unclear.
Integrins, as the main receptors that connect the cytoskeleton
and the extracellular matrix (ECM), have been shown to play
important roles in transmitting mechanical stresses into
chemical signals in a wide variety of cells seeded on the
ECM.
(15) Human osteoblasts express several types of integrins,
including those containing the b1 subunit (dimerized with a
subunits, including a1, a3, a5, and a6),
(16) which have been
shown to play important roles in osteoblast differentiation and
commitment.
(17) In several systems, including endothelial cells,
shear stress activation of integrins leads to an increase in their
association with an adaptor protein, Shc, that subsequently
activates the downstream mitogen-activated protein kinases
(MAPKs), including extracellular signal-regulated kinase (ERK)
and p38 MAPK.
(18) Recent studies demonstrated that estrogen
induces b1-integrin expression and adhesive properties in
endothelial cells.
(19) Although integrins have been well recog-
nized as mechanosensors in a variety of cells in response to
mechanical stimuli, whether estrogen regulates mechanical
responsiveness of signaling and gene expression in osteoblasts
by modulating their integrin expression remains unclear.
In this study, we investigated the synergistic role of estrogen
and shear stress in signaling and gene expression in both human
osteoblast-like MG63 cells and primary osteoblasts (HOBs) using
activations of ERK and p38 MAPK and expressions of c-fos and
Cox-2 as readouts. MG63 cells were derived originally from an
osteogenic sarcoma of a 14-year-old boy and exhibit many
osteoblast traits characteristic of bone-forming cells.
(20) Our
results showed that pretreatment of MG63 cells and HOBs with
17b-estradiol enhances shear stress–induced activations of ERK
and p38 MAPK and expressions of c-fos and Cox-2 through
ER-mediated increases in b1-integrin expression. Our findings
provide insights into the mechanism by which estrogen
augments shear stress responsiveness of signal transduction
and bone-formation-related gene expression in bone cells via
ER-mediated induction of b1-integrin.
Materials and Methods
Materials
Mouse monoclonal antibodies (mAbs) against ERK2 (sc-1647)
and phospho-ERK1/2 (sc-7383) were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA, USA). Rabbit polyclonal antibody
(pAb) against p38 MAPK and mouse mAb against phospho-p38
MAPK were purchased from Cell Signaling Technology (Beverly,
MA,USA).MousemAbagainsthumanb1-integrinwaspurchased
from Chemicon (MAB 2253, Temecula, CA, USA). The phycoer-
ythrin (PE)–conjugated mouse anti-human CD29 (b1-integrin
chain) antibody was purchased from BD Biosciences (San Jose,
CA, USA). The control small interfering RNA (siRNA) and specific
siRNA of b1-integrin were purchased from Invitrogen (Carlsbad,
CA,USA).ThetypeIcollagen,charcoal(dextrancoated),and17b-
estradiol were obtained from Sigma (St. Louis, MO, USA). The ICI
182,780 was purchased from Torics (Ellisville, MO, USA). All other
chemicals of reagent grade were obtained from Sigma unless
otherwise noted.
Cell culture
The human osteoblast-like MG63 cells were obtained from
AmericanTypeCultureCollection(Rockville,MD,USA)andcultur-
ed in a phenol red–free medium (a-MEM, Gibco, Gaithersburg,
MD, USA) supplemented with 10% fetal bovine serum (FBS,
Gibco). Human bone specimens were collected aseptically
duringorthopedicsurgeryofthekneeorthehip,andtheprimary
HOBs were harvested and cultured by using the method
described previously.
(10) Osteocalcin expression and alkaline
phosphatase activity were examined to confirm the osteoblastic
phenotype of HOBs. The HOBs were cultured in a phenol red–
free medium (DMEM, Gibco) supplemented with 20% FBS. After
reaching confluence, these cells were trypsinized and seeded
onto glass slides (75 38 mm, Corning Incorporated, Corning,
NY, USA) that had been precoated with type I collagen (30mg/
mL) at a concentration of 10
4 cells/cm
2. The cells were incubated
inphenolred–freea-MEMsupplementedwith10%FBS(pretreat-
ed with charcoal to remove endogenous estrogen in the serum)
for 24hrs. The medium then was changed to phenol red– and
serum-free a-MEM containing 0.25% bovine serum albumin
(BSA) for incubating the cells for 48hrs prior to the experiments.
Flow apparatus
The slide with cultured MG63 cells or HOBs was mounted in a
parallel-plate flow chamber, which has been characterized and
described in detail elsewhere.
(21) The chamber was connected to
a perfusion loop system, kept in a constant temperature-
controlled enclosure, and maintained at pH 7.4 by continuous
gassing with humidified 5% CO2 in air. The flow channel width
(w) was 1cm, and the channel height (h) was 0.025cm. The fluid
shear stress (t) generated on the cells by flow was calculated to
be 12 dyn/cm
2, using the formula t¼6mQ/wh
2, where m is
the dynamic viscosity of the perfusate and Q is the flow rate. In
some experiments, MG63 cells or HOBs were incubated with the
specific inhibitor for ERs (ICI 182,780, 10nM), ERK (PD98059,
30mM), or p38 MAPK (SB203580, 10mM) for 1hr before
stimulation with 17b-estradiol (10nM) or exposure to flow.
Western blot analysis
The cells were lysed with a buffer containing 1% NP-40, 0.5%
sodiumdeoxycholate,0.1%SDS,andaproteaseinhibitormixture
(PMSF, aprotinin, and sodium orthovanadate). The total cell
lysate (100mg of protein) was separated by SDS-PAGE (12%
running, 4% stacking) and analyzed by using the designated
antibodies and the Western-Light chemiluminescent detection
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previously.
(21)
RNA isolation and reverse transcriptase-polymerase chain
reaction (RT-PCR)
Total RNA was isolated by the guanidium isothiocyanate/
phenochloroform method and converted to cDNA, as described
previously.
(21)RT-PCRanalysiswasperformed withtheRTSystem
(Promega, San Luis Obispo, CA, USA) according to the
manufacturer’s protocols. Briefly, the RT reaction with 2mgo f
total RNA was performed with the following cycles: 658C for
5 minutes, 428C for 50minutes, 708C for 15minutes, and 378C for
20minutes. For each reaction, cDNA from the RT reaction was
amplifiedbyPCRwiththeuseof2.5unitsofTaqDNApolymerase
(Promega) and the b1-integrin primers, as shown in Table 1. The
PCR reactions were carried out in a GeneAmps System 9700
(PE Biosystems, Foster City, CA, USA). The PCR cycles for each
reaction were as follows: heat denaturation at 948C for
30seconds, primer annealing at 608C for 30seconds, and primer
extension at 728C for 45seconds. The amplified cDNAs were
analyzed by 1% agarose gel electrophoresis and ethidium
bromide staining. Band intensities were quantified from the
stained agarose gels using video imaging and a densitometry
software system (GDS-8000 Imaging Workstation, UVP, Inc.,
Upland, CA, USA).
Quantitative real-time PCR
The cDNA was amplified through PCR on a LightCycler (Roche
Diagnostics, East Sussex, United Kingdom) using LightCycler
FastStart DNA MasterPlus SYBR Green I (Roche Diagnostics) with
0.5mM primers of c-fos and Cox-2 genes (see Table 1). PCR was
performed in triplicate at 958C for 10minutes, followed by 45
cycles of denaturation at 958C for 10seconds, annealing at 608C
for 5seconds, extension at 728C for 8seconds, and single signal
acquisitionfor10seconds.Theb-actingeneexpressionwasused
as an internal control. The PCR conditions were optimized to
obtain a PCR product with a single peak on melting-curve
analysis on the LightCycler. Raw data collected from the
LightCycler were analyzed using LightCycler Software Version
3.5 (Roche Diagnostics). The c-fos and Cox-2 gene expression
levels were normalized with b-actin gene expression level in the
same sample.
Flow cytometric analysis
The cells were harvested in PBS containing 2mM ethylene
diamine tetraacetic acid, washed twice with 0.5% BSA and then
stained with PE-conjugated mouse anti-human CD29 (b1-
integrin chain) antibody for 30minutes. The stained cells were
washedtwicewith0.5%BSAandthenfixedincoldethanol(70%)
for 30minutes. Fixed cells were washed and analyzed with a
fluorescence-activated cell sorter (FACS; Calibur, Becton-Dick-
inson, Franklin Lakes, NJ, USA), and the data were analyzed using
a mod-fit b1-integrin expression analysis program.
siRNA and Transfection
For siRNA transfection, the cells at 70–80% confluence were
transfected with the designated siRNA at various concentrations
(10–40nM) for 48hrs using the RNAimax transfection kit
(Invitrogen, Carlsbad, CA, USA) and then stimulated with 17b-
estradiol or exposed to flow.
Statistical analysis
Results are expressed as mean SEM. Statistical analysis was
performed by using an independent Student’s t test for two
groups of data and analysis of variance (ANOVA) followed by
Scheffe’s test for multiple comparisons. A p value of less than .05
was considered significant.
Results
Estrogen augments shear stress–induced ERK and p38
MAPK phosphorylations in MG63 cells
We first examined the individual effects of estrogen and shear
stress on the activations of ERK and p38 MAPK in MG63 cells.
MG63 cells were stimulated with 17b-estradiol (10nM) for 5, 15,
and 30minutes and 1, 3, and 6 hours, and their phosphorylations
of ERK and p38 MAPK were determined by Western blot analysis.
As shown in Figure 1A, stimulation of MG63 cells with 17b-
estradiol induced a rapid increase (significant within 5minutes)
intheERKphosphorylationinthesecells.Incontrast,theincrease
inp38 MAPKphosphorylationinducedby17b-estradiolwaslater
(significant within 1hour). These increased levels of ERK and
p38 MAPK phosphorylations decreased to nearly the basal
levels 30minutes and 6hrs, respectively, after 17b-estradiol
stimulation. Application of shear stress (12dyn/cm
2) to MG63
Table 1. Primer Sequences and the Number of Reaction Cycles Used for RT-PCR
Gene name Gene bank accession number Primer sequence Size (bp) Number of cycles
c-fos V01512 F-TGCTTTCAGACTGGGCTCTT 73 45
R-GCAGAATAGGTGTGACTTGCAT
Cyclooxygenase-2 U04636 F-TCACGCATCAGTTTTTCAAGA 94 45
(Cox-2) R-TCACCGTAAATATGATTTAAGTCCAC
b-actin NM001101 F-AAATCGTCCGTGACATCAAG 180 45
R-GGAAGGAAGGCTGG AAGA GA
b1-integrin NM002211 F-ACAGAAGAAGTAGAGGTGGTC 660 30
R-GAGGTTGAAATGGGAGG
GAPDH AF261085 F-CCACCCATGGCAAATTCCATGGCA 599 27
R-TCTAGACGGCAGGTCAGGTCCACC
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in ERK and p38 MAPK phosphorylations in comparison with
static controls (see Fig. 1B). These increased levels of ERK and
p38 MAPK phosphorylations decreased to nearly the basal
levels 30minutes and 1hour, respectively, after exposure to
flow.
To investigate the synergistic effect of estrogen and shear
stress on the ERK and p38 MAPK activations, MG63 cells were
treated with 17b-estradiol for 6hrs and then exposed to flow for
10minutes in the presence of 17b-estradiol. The activations of
ERK and p38 MAPK in these cells were compared with those in
the cells stimulated with 17b-estradiol and shear stress alone. As
Fig. 1. Estrogen augments shear stress–induced ERK and p38 MAPK phosphorylations in MG63 cells. MG63 cells were kept as controls or stimulated with
17b-estradiol (E2; 10nM) (A) or shear stress (12 dyn/cm
2)( B) for the times indicated, and their ERK and p38 MAPK phosphorylations were determined by
usingWesternblotanalysis.(C)Cellsweretreatedwith17b-estradiolfor6hoursandthenkeptinstaticconditionorexposedtoshearstressfor10minutes.
(D) Cells were subjected to simultaneous stimuli with shear stress and 17b-estradiol for 10minutes in the absence of 17b-estradiol pretreatment. The
amountsofphosphorylatedERK andp38 MAPKin stimulated cellsarepresented as banddensities(normalizedtothetotal proteinlevels)relativeto those
in unstimulated control cells. The results are mean SEM from three independent experiments.
 p<.05 versus unstimulated control cells.
#p<.05 versus
sheared cells without 17b-estradiol pretreatment (C).
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before exposure to shear stress resulted in higher levels of ERK
and p38 MAPK phosphorylations in these cells than in the cells
exposed to shear stress alone. These results suggest that
pretreatment of MG63 cells with estrogen before shearing
augments the shear stress–induced ERK and p38 MAPK
phosphorylations in these cells. This augmented effect of
estrogen on shear stress–induced ERK and p38 MAPK phosphor-
ylations was not seen in cells exposed to simultaneous stimuli
with shearstress and 17b-estradiol for 10minutes in the absence
of 17b-estradiol pretreatment (see Fig. 1D).
Estrogen induces b1-integrin expression in MG63 cells
through ERs
To investigate the effect of estrogen on b1-integrin expression in
MG63 cells, MG63 cells were treated with 17b-estradiol (10nM)
for 5, 15, and 30minutes and 1, 3, and 6hrs, and their mRNA
expression was examined by RT-PCR. As shown in Figure 2A, the
mRNA levels of b1-integrin were induced by 17b-estradiol at
30minutes and remained elevated over the 6hr period tested.
The results of Western blot analysis showed that treatment of
MG63 cells with 17b-estradiol induces b1-integrin protein
expression within 1hr of stimulation (see Fig. 2B). These
increased levels of b1-integrin protein remained for 9hrs and
then declined to the basal levels 12hrs after stimulation. The
estrogen-induced increases in b1-integrin expression were
confirmed by flow cytometric analysis, which showed that
stimulation of MG63 cells with 17b-estradiol for 6 hours resulted
in an increase in b1-integrin surface expression, with a mean
fluorescence intensity of 388 compared with 241 in untreated
cells, and that the b1-integrin decreased to near the control level
(see Fig. 2C), in agreement with the Western blot result in Fig. 2B.
These results indicate that estrogen induces gene and protein
expressions of b1-integrin in MG63 cells, which is accompanied
by the increase in b1-integrin expression on the cell surface.
To investigate whether ERs are required for estrogen-induced
b1-integrin expression in MG63 cells, MG63 cells were pretreated
with ICI 182,780 (1mM), a specific ER antagonist, for 1 hour and
then stimulated with 17b-estradiol (10nM) for 6hrs. The MG63
cell expression of b1-integrin was examined by both Western
blot and flow cytometric analyses. As shown in Fig. 2D,
stimulation of MG63 cells with 17b-estradiol for 6hrs induced
their b1-integrin expression. Pretreatment of MG63 cells with ICI
182,780 before 17b-estradiol stimulation inhibited the 17b-
estradiol-induced b1-integrin expression. As a control, ICI
182,780 did not have effect on the basal levels of b1-integrin
expression inMG63 cells. The inhibition in17b-estradiol-induced
b1-integrin expression by ICI 182,780 was confirmed by flow
cytometric analysis, which showed that stimulation with 17b-
estradiol resulted in an increase in b1-integrin protein expression
on MG63 cell surface, with a mean fluorescence intensity of 334
compared with 226 in control unstimulated cells (see Fig. 2E);
pretreating MG63 cells with ICI 182,780 reduced 17b-estradiol-
induced b1-integrin expression to a mean fluorescence intensity
of 251. These results indicate that ERs are required for estrogen
induction of b1-integrin expression in MG63 cells.
Estrogen-mediated augmentation of shear stress–
induced ERK and p38 MAPK activations in MG63 cells is
mediated by ERs through b1-integrin
Given our findings that estrogen augments shear stress–induced
ERK and p38 MAPK activations in MG63 cells and that estrogen
induces b1-integrin expression through ERs, we investigated
whether the augmented effect of estrogen on shear stress–
induced ERK and p38 MAPK activations is mediated by ERs
through b1-integrin. To this end, MG63 cells were kept as
controls or pretreated with ICI 182,780 for 1hr and then
stimulated with 17b-estradiol for 6 hours, followed by exposure
to shear stress at 12 dyn/cm
2 for 10minutes. As shown in
Figure 3A, treatment of MG63 cells with 17b-estradiol before
shearing augmented shear stress–induced ERK and p38 MAPK
phosphorylations in MG63 cells compared with cells exposed to
flow in the absence of 17b-estradiol pretreatment. Pretreating
MG63 cells with ICI 182,780 before 17b-estradiol and shear stress
stimuli inhibited this augmented effect of 17b-estradiol on shear
stress–induced ERK and p38 MAPK phosphorylations but did not
inhibit the increases in ERK and p38 MAPK phosphorylations
induced by shear stress alone. Transfection of MG63 cells with
b1-specific siRNA (40 nM, compared with control siRNA), which
almost totally abolished the b1-integrin protein expression,
inhibited the shear stress–induced ERK and p38 MAPK
phosphorylations and the augmented effect of 17b-estradiol
on shear activations of these MAPKs in MG63 cells (see Fig. 3B).
Transfecting with b1-specific siRNA also inhibited the 17b-
estradiol-induced ERK and p38 MAPK phosphorylations in MG63
cells (see Fig. 3C). Taken together, these results suggest that (1)
the ERK and p38 MAPK activations in MG63 cells induced by
shear stress alone are mediated by b1-integrin but not ERs, and
(2) the augmented effect of estrogen on shear-induced ERK and
p38 MAPK activations are mediated by both ERs and b1-integrin.
Estrogen augments shear stress–induced c-fos and
Cox-2 expressions in MG63 cells through ERK and
p38 MAPK pathways
MG63 cells were kept as controls or exposed to shear stress
(12dyn/cm
2) for 15 and 30minutes and and 1hr, and their
expression of c-fos and Cox-2 genes was examined by
quantitative real-time PCR. Exposure of MG63 cells to shear
stress induced c-fos and Cox-2 mRNA expressions (Fig. 4A) within
15minutes. For 1hr of testing, the longer the duration of
shearing,thegreaterwastheincreaseinCox-2mRNAexpression.
In contrast, the increased expression of c-fos mRNA declined but
still elevated after 1hr of flow application. Pretreating MG63 cells
with specific inhibitor of either ERK (e.g., PD98059; 30mM) or p38
MAPK (i.e., SB203580; 10mM) or the combination of both
inhibitors resulted in inhibitions, at least in part, in shear stress–
induced c-fos and Cox-2 expressions (see Fig. 4B), indicating that
both ERK and p38 are involved inshear stress inductions of these
two bone-formation-related genes in MG63 cells. The expres-
sions of c-fos and Cox-2 in MG63 cells were induced by treating
with 17b-estradiol alone within 30minutes (Fig. 4C). These
increased levels of c-fos and Cox-2 mRNAs were declined to the
basal levels 3 hours after 17b-estradiol stimulation.
ESTROGEN ENHANCES SHEAR RESPONSIVENESS OF OSTEOBLASTS Journal of Bone and Mineral Research 631Fig. 2. Estrogen induces b1-integrin expression in MG63 cells through ERs. MG63 cells were kept as controls or stimulated with 17b-estradiol (E2; 10nM)
for the times indicated (A–C). In some experiments, MG63 cells were kept as controls (C) or pretreated with ICI 182,780 (ICI; 1mM) for 1hr and then
stimulatedwith17b-estradiol(E2;10nM)for6hrs(ICIþE2)(D,E).Theb1mRNAandproteinexpressionsweredeterminedbyusingRT-PCR(A),Westernblot
(B, D), and flow cytometric (C, E) analyses, respectively. The results are shown as mean SEM from three separate experiments. Data in panels A, B, and D
are presented as percentage changes in band density from unstimulated control cells and normalized to GAPDH (A)o ra-tubulin protein level (B, D). In
panels C and E, MG63 cells incubated with FITC-conjugated antibody alone were used as blanks. Numbers are mean SEM of mean fluorescent intensity
for all experiments determined by comparison with corresponding blanks.
 p<.05 versus unstimulated control cells.
#p<.05 versus E2-treated cells (D).
632 Journal of Bone and Mineral Research YEH ET AL.Fig. 3. Estrogen-mediated augmentation of shear stress–induced ERK and p38 MAPK activations in MG63 cells is regulated by ERs and b1-integrin. MG63
cells were kept as controls or pretreated with ICI 182,780 (ICI; 1mM) for 1hr and then stimulated with 17b-estradiol (E2; 10nM) for 6hrs, followed by
exposure to shear stress (S; 12 dyn/cm
2) for 10minutes (E2þS) (A). In parallel experiments, MG63 cells were transfected with control (siCL) or b1-integrin-
specific siRNA (sib1) for 48 hours prior to 17b-estradiol and shear stress stimuli (B). (C) Cells were transfected with control or b1-integrin-specific siRNA for
48hrsandthenkeptascontrolsortreatedwith17b-estradiolfor15minutes(forERK)or1hr(forp38MAPK).ThephosphorylationsofERKandp38MAPKin
these cells were determined by Western blot analysis. Data are presented as the amounts (band densities normalized to the total protein levels) of
phosphorylated ERK and p38 MAPK proteins relative to those in static control cells pretreated with vehicle control (A) or transfected with control siRNA (B,
C) and are shown as mean SEM from three independent experiments.
 p<.05 versus unstimulated control cells.
#p<.05 versus sheared cells without
17b-estradiol pretreatment.
§p<.05 versus 17b-estradiol/shear stress–stimulated cells pretreated with vehicle control (A) or transfected with control
siRNA (B, C).
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stress on the expressions of c-fos and Cox-2, MG63 cells were
treated with 17b-estradiol for 6hrs and then exposed to flow for
15minutes (for c-fos) or 1hr (for Cox-2). Pretreatment of MG63
cells with 17b-estradiol before shearing resulted in an
augmentation of shear stress–induced c-fos and Cox-2
expressions compared with cells exposed to flow in the absence
of 17b-estradiol pretreatment (Fig. 4D). However, this estrogen
augmentation of shear stress–induced c-fos and Cox-2 expres-
sions was not seen in cells exposed to simultaneous stimuli with
shear stress and 17b-estradiol for 15 and 30minutes in the
absence of 17b-estradiol pretreatment (see Fig. 4E). Pretreating
Fig. 4. Estrogenaugmentsshearstress–inducedc-fosandCox-2expressionsinMG63cells.MG63cellswerekeptas controls(C),exposedtoshearstressat
12dyn/cm
2(S)(A),orstimulatedwith17b-estradiol(E2;10nM)(C)forthetimesindicated,andtheirc-fosandCox-2mRNAexpressionsweredeterminedby
quantitative real-time PCR. In some experiments, MG63 cells were pretreated with vehicle control DMSO or specific inhibitor of ERK (PD98058; 30mM) or
p38 MAPK(SB203580; 10mM)or a combination oftheseinhibitorsfor1hr before exposureto shearstress for15minutes(for c-fos)or 1 hour(for Cox-2)( B).
Inparallelexperiments,thecellswerestimulatedwith17b-estradiolfor6hrsandthenexposedtoshearstressfor15minutes(forc-fos)or1hour(forCox-2)
(E2þS)(D). Priorto 17b-estradiolandshearstress treatments, thecellswerepreincubatedwith PD98058orSB203580ora combination oftheseinhibitors
for 1 hour ( F). (E) MG63 cells were subjected to simultaneous stimuli with shear stress and 17b-estradiol for 15 and 30 minutes without 17b-estradiol
pretreatment. Data are presented as percentage changes relative to the unstimulated control cells (normalized to b-actin gene expression) and shown as
meanþSEM from three or four separate experiments.
 p<.05 versus unstimulated control cells.
#p<.05 versus sheared cells without inhibitor
pretreatment (B).
§p<.05 versus sheared cells without 17b-estradiol pretreatment (D, F).
dp<.05 versus sheared/E2-treated cells without inhibitor
pretreatment ( F).
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a combination of these inhibitors abolished the estrogen
augmentation of shear stress–induced c-fos and Cox-2 expres-
sions (see Fig. 4F), suggesting that the augmented effect of
estrogen on shear induction of c-fos and Cox-2 in MG63 cells is
mediated by the ERK and p38 MAPK pathways.
The estrogen augmention of shear stress–induced c-fos
and Cox-2 expressions is mediated by ERs through b1-
integrin
MG63 cells were kept as controls or pretreated with ICI 182,780
for1hrandthenstimulatedwith17b-estradiolfor6hrs,followed
by exposure to shear stress at 12 dyn/cm
2 for 15minutes (for c-
fos) or 1 hour (for Cox-2). The expressions of the c-fos and Cox-2
genes in these cells were examined by quantitative real-time
PCR. Application of shear stress to MG63 cells induced their c-fos
and Cox-2 mRNA expressions (Fig. 5A). These shear stress–
induced expressions of mRNAs were augmented by pretreating
the cells with 17b-estradiol before shearing. Pretreating MG63
cells with ICI 182,780 before 17b-estradiol and shear stress
stimuli resulted in inhibitions in the augmented effect of 17b-
estradiol on shear inductions ofc-fos and Cox-2 but did not affect
the induction of these genes by shear stress (as compared with
the application of shear stress alone). In parallel experiments,
MG63 cells were transfected with control or b1-specific siRNA
(40nM) and then treated with 17b-estradiol for 6hours, followed
byexposuretoshearstressfor15minutes(forc-fos)or1hour(for
Cox-2). As shown in Fig. 5B, transfection of MG63 cells with b1-
specific siRNA (compared with control siRNA) inhibited not only
the shear inductions of c-fos and Cox-2 but also the augmenta-
tion effect of 17b-estradiol on shear inductions of these genes.
Taken together with our findings that estrogen induces b1-
integrin expression through ERs, these results suggest that the
augmentation effect of estrogen on shear inductions of c-fos and
Cox-2 in MG63 cells is mediated by ERs through b1-intergrin.
Confirmation of the augmented effect of estrogen on
shear-induced signaling and gene expression in primary
HOBs
Since MG63 cells are a highly transformed cell line derived
originally from an osteogenic sarcoma (despite sharing some
properties characterized for osteoblasts), we examined whether
similar results on the effect of estrogen on shear-induced
signaling and gene expression in MG63 cells can be obtained
with primary HOBs. As shown in Figure 6, HOBs pretreated with
17b-estradiol for 6 hours with subsequent exposure to shear
stress had higher levels of ERK and p38 MAPK phosphorylations
(seeFig.6A)andc-fosandCox-2expressions(seeFig.6B)thanthe
cells exposed to shear stress alone. Treating HOBs with 17b-
estradiol for 6 hours resulted in an increase in b1-integrin surface
expression; this estrogen induction of b1-integrin was inhibited
by pretreating the cells with ICI 182,780 (see Fig. 6C). Moreover,
transfecting HOBs with b1-specific siRNA (compared with control
siRNA; 40nM for each) resulted in inhibitions, at least in part, in
shear-induced ERK and p38 MAPK phosphorylations (see Fig. 6D)
and c-fos and Cox-2 expressions (see Fig. 6E), as well as the 17b-
estradiol-mediated augmentation of these shear-induced MAPK
signaling and gene expressions in these cells. However, in
contrast to MG63 cells, HOBs transfected with b1-specific siRNA
had higher basal levels of MAPK signaling and c-fos and Cox-2
expressions than the control siRNA-transfected cells. These
results confirm the role of estrogen in modulating shear stress–
induced signaling and gene expression through ER induction of
b1-integrin in primary HOBs.
Discussion
The aim of this study was to investigate the synergistic role of
estrogen and shear stress in signal transduction and gene
expression in human osteoblast-like MG63 cells and primary
Fig. 5. Estrogen-mediated augmentation of shear stress–induced c-fos and Cox-2 expressions is mediated by both ERs and b1-integrin. MG63 cells were
keptascontrolsorpretreatedwithICI182,780(ICI;1mM)for1hr(A)andthenstimulatedwith17b-estradiol(E2;10nM)for6hours,followedbyexposureto
shear stress (S; 12 dyn/cm
2) for 15minutes (for c-fos) or 1hour (for Cox-2)( A). In parallel experiments, MG63 cells were transfected with control (siCL) or
specific siRNA of b1-integrin (sib1) for 48hours prior to 17b-estradiol and shear stress stimuli (B). The expressions of c-fos and Cox-2 mRNA were
determined by quantitative real-time PCR. Data are presented as the expression (normalized to the b-actin gene expression) of c-fos or Cox-2 relative to
thosein static controlcellspretreatedwith vehiclecontrol(A) or transfected withcontrolsiRNA(B) andareshownas mean SEMfromthree independent
experiments.
 p<.05 versus unstimulated control cells.
#p<.05 versus sheared cells without 17b-estradiol pretreatment.
§p<.05 versus 17b-estradiol/
shear stress–stimulated cells pretreated with vehicle control (A) or transfected with control siRNA (B).
ESTROGEN ENHANCES SHEAR RESPONSIVENESS OF OSTEOBLASTS Journal of Bone and Mineral Research 635Fig. 6. Confirmation on the augmented effect of estrogen on shear stress–induced signaling and gene expression in primary HOBs. Primary HOBs were
kept as controls or stimulated with 17b-estradiol (E2; 10nM) for 6hrs and then exposed to shear stress at 12 dyn/cm
2 for 10minutes (for MAPK) (A),
15minutes (for c-fos), or 1hr (for Cox-2)( B). The phosphorylations of ERK and p38 MAPK (A) and expressions of c-fos and Cox-2 (B) in these cells were
determined by using Western blot and quantitative real-time PCR, respectively. In parallel experiments, HOBs were transfected with control (siCL) or
specific siRNA (40nM) of b1-integrin (sib1) for 48hrs prior to 17b-estradiol and/or shear stress stimuli (D, E). (C) Flow cytometric analysis of b1-integrin
surface expression on HOBs treated with 17b-estradiol for 6hrs. In some experiments, HOBs were pretreated with ICI 182,780 (ICI; 1mM) for 1hr prior to
17b-estradiol stimulation. HOBs incubated with FITC-conjugated antibody alone were used as blanks. Data in panels A, B, D, and E are presented as
percentage changes relative to the unstimulated control cells [normalized to the MAPK total protein levels (A, D)o rb-actin gene expression (B, E)] and
shown as mean SEM from three separate experiments. Numbers in panel C are mean SEM of mean fluorescent intensity for three experiments
determined by comparison with corresponding blanks.
 p<.05 versus unstimulated control cells.
#p<.05 versus sheared cells without 17b-estradiol
pretreatment.
§p<.05 versus 17b-estradiol/shear stress–stimulated cells transfected with control siRNA (D, E).
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expressions of c-fos and Cox-2 as readouts. Through a series
of systematic studies, we have demonstrated that estrogen
augments the shear stress–induced ERK and p38 MAPK
activations and c-fos and Cox-2 expressions in osteoblast-like
cells through ER-mediated increases in b1-integrin expression.
Several lines of evidence support this conclusion. First, MG63
cells treated with 17b-estradiol for 6hrs followed by exposure to
shear stress had higher levels of ERK and p38 MAPK
phosphorylations and c-fos and Cox-2 expressions than the cells
exposedonly to shear stress without 17b-estradiol pretreatment.
Second,MG63cellsstimulatedwith17b-estradiolfor6hourshad
higher levels of b1-integrin mRNA and protein expressions than
the unstimulated cells. Blockage of ERs by the ER-specific
antagonist ICI 182,780 inhibited the 17b-estradiol-induced b1-
integrin expression in MG63 cells. Third, pretreating MG63 cells
with ICI 182,780 or transfecting the cells with b1-specific siRNA
inhibited the augmentation effects of 17b-estradiol on shear
stress–induced ERK and p38 MAPK phosphorylations and c-fos
and Cox-2 expressions in MG63 cells. Fourth, similar results on
the augmented effect of estrogen on MAPK signaling and c-fos
and Cox-2 expressions were obtained using HOBs. Our findings
provide insights into the mechanism by which estrogen and
shear stress play synergistic roles in modulating signaling and
gene expression in osteoblast-like cells.
Both estrogen and mechanical forces have been shown to be
positive regulators for osteoblast proliferation and bone
formation.
(22–25) However, the synergistic roles of these two
stimulators in modulating signaling and gene expression in
osteoblasts remain unclear. Jagger and colleagues
(26) demon-
strated that estrogen administration augments compressive
force–induced osteogenic response in rat caudal vertebrae.
Joldersma and colleagues
(27) showed that estrogen enhances
shear stress–induced production of prostaglandin E2 (PGE2)b y
osteoblasts derived from postmenopausal and nonosteoporotic
women. Bakker and colleagues
(28) showed that estrogen and
shearstressexertadditiveeffectsontheproductionsofPGE2and
nitric oxide by bone cells derived from osteoporotic women
(aged 62–90 years). These results suggest that estrogen may
affect the signaling and function of bone cells in response to
mechanical forces, which consequently may affect the mechan-
oresponsiveness of bone in the process of bone formation and
remodeling. In this study, we demonstrated for the first time that
pretreatment of osteoblast-like MG63 cells and HOBs with
estrogen augments the shear stress–induced ERK and p38 MAPK
phosphorylations and c-fos and Cox-2 expressions. These results
indicate that estrogen may regulate mechanosensitivity of bone
cells via the MAPK pathway, which may result in the increased
expression of bone-formation-related genes, for example, c-fos
and Cox-2, and the consequent modulation in bone formation
and remodeling in response to mechanical stimuli.
Several studies have indicated that ERs may play important
roles in bone formation and adaptation in response to
mechanical forces.
(29–31) Lee and colleagues
(29) applied mechan-
ical strain to the ulnae of ERa knockout (ERa
 / ) mice and found
that the strain-induced bone formation of cortical bone in ERa
 /
  mice is only one-third of that in ERa
þ/þ littermates. They
further demonstrated that osteoblast-like cells derived from
ERa
 /  mice have deficient response to mechanical strain.
(30)
Damien and colleagues
(31) showed that mechanical strain
stimulates osteoblast proliferation through ERs in males as well
as females. Aguirre and colleagues
(32) demonstrated that the ER
antagonist ICI 182,780 abrogates ERK activation induced by
cyclicstretchinosteocyticcellsandthatERaandERbexpressions
are required for ERK activation by cyclic stretch in osteoblastic
and osteocytic cells. These results have been interpreted to
suggest that ERs may serve as mechanosensors to play
significant roles in modulating bone cell signaling and function
and hence bone formation in response to mechanical stimuli.
Using antibodies against phosphorylated ER-a, our recent
studies did show that application of shear stress at 12 dyn/
cm
2 to MG63 cells induces their ER-a phosphorylation (data not
shown). However, this study shows that blockage of ERs by ICI
182,780 did not inhibit shear stress–induced ERK and p38 MAPK
phosphorylations and c-fos and Cox-2 expressions in MG63 cells,
indicating that ERs may not be involved in the effect of shear
stress per se on MAPK signaling and gene expression in MG63
cells. The detailed mechanisms underlying the discrepancy in
biologic effects of ERs on mechanical responses of cells between
our present results and previous studies remain unclear. Recent
studies have indicated that different patterns of mechanical
force application (e.g., steady versus oscillatory patterns of shear
forces) exert differential effects on cell signaling, gene expres-
sion, and function through different molecular mechanisms.
(33)
Whether different types of mechanical loading, such as the
steady fluid shear stress used in this study and cyclic stretch/
strain used in other reports, induce signaling and gene
expression in cells through different mechanisms remain to
be determined. Our present results show that blockage of ERs by
ICI 182,780 resulted in a reduction in the augmentation effects of
estrogen on shear stress–induced ERK and p38 MAPK phosphor-
ylations and c-fox and Cox-2 expressions in MG63 cells,
suggesting that ERs are involved in the estrogen-induced
augmentation of shear stress responsiveness of signal transduc-
tion and gene expression in osteoblast-like cells.
Integrins play significant roles in mechanical responses of cells
on the ECM. A recent study by Plotkin and colleagues
(34)
demonstrated that the effect of mechanical stretch on osteocytic
cells can be transmitted by integrins, which are required for
mechanical stretch–induced activation of ERK that plays
important roles against cell apoptosis induced by different
stimuli. In vascular endothelial cells, estrogen has been shown to
induce b1-integrin expression and hence cell attachment and
migration, which consequently may promote neovascularization
and vessel repair.
(19) This may be the reason for the observation
that women prior to menopause have a lower cardiovascular risk
but a higher incidence of several blood vessel–related
autoimmune diseases, including Takayasu arteritis and systemic
lupus erythematosus, than men.
(35–37) The results of our present
study showed that estrogen can induce the mRNA and protein
expressions of b1-integrin in osteoblast-like MG63 cells and
HOBs, in addition to endothelial cells. This estrogen-induced
expression of b1-integrin requires ERs and contributes to the
augmentation effects of estrogen on shear stress–induced ERK
and p38 MAPK signaling and c-fos and Cox-2 expressions in
these osteoblast-like cells and HOBs. These results suggest that
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signaling and gene expression in osteoblastic cells in response
to the synergistic interaction of chemical and mechanical stimuli,
for example, estrogen and shear stress.
In this study, shear stress was applied to the cells at the time
point where the effects of estrogen on MAPK signaling and c-fos
and Cox-2 gene expressions have subsided (i.e., 6 hours of 17b-
estradiol pretreatment before shearing). This treatment schedule
allows us to clarify whether estrogen could exert effects on shear
stress–induced signaling and gene expression even though its
individual effect has disappeared. To elucidate whether the
effect of shear stress still could be enhanced by estrogen applied
together with shear stress without pretreatment, MG63 cells
were subjected to shear stress in the presence of 17b-estradiol
for 10minutes (for MAPK) and 15 and 30minutes (for c-fos and
Cox-2), and the results showed that simultaneous stimuli with
shear stress and estrogen did not result in an augmentation in
shear stress–induced MAPK signaling (see Fig. 1D) and gene
expression (see Fig. 4E) in MG63 cells compared with cells
exposedtoshearstressalone. Thelackofanaugmentedeffectof
estrogen on shear stress–induced signaling and gene expression
in these experiments could be due to the short exposure times
(i.e., 10, 15, and 30minutes), where the b1-integrin protein
expression has not been induced by estrogen.
The proto-oncogene c-fos has been shown to be involved in
mitogenic responses of osteoblastic cells.
(38) Stable expression of
c-fos in mice has been demonstrated in developing bones,
cartilages, and teeth.
(39) Overexpression of c-fos in transgenic
and chimeric mice enhances bone and cartilage develop-
ment.
(40) In contrast, homozygous c-fos
 /  mice are growth-
retarded and develop osteopetrosis, with deficiencies in bone
remodeling and tooth eruption, compared with normal
littermates.
(41) Recent studies have demonstrated that estrogen
induces c-fos expression in rat bone.
(42) In addition, mechanically
induced bone formation has been shown to be preceded by the
expression of c-fos in the whole animal.
(43) These results suggest
that c-fos protein may serve as a critical molecule for bone
formation and development and that c-fos expression may be
affected by estrogen and mechanical forces in vivo. Cox-2 is a
rate-limiting enzyme in the conversion of membrane-related
arachidonic acid to prostaglandins to mediate the stimulatory
effects of estrogen and mechanical loading on bone forma-
tion.
(44,45) Cox-2
–/– mice have decreased bone density in
comparison with normal littermates.
(46) Bending forces applied
to the tibiae of rats were found to increase Cox-2 and c-fos mRNA
expressions in vivo.
(46) These reports suggest that the expres-
sions of c-fos and Cox-2 may play significant roles in estrogen-
and mechanical loading–induced bone formation and remodel-
ing. In this study, we demonstrated that both estrogen and
mechanical forces can induce c-fos and Cox-2 expressions in
osteoblast-like cells. Our study further demonstrated that
estrogen and shear stress can exert additive effects on the
induction of c-fos and Cox-2 expressions in osteoblast-like cells,
suggesting that estrogen and mechanical forces may play
synergistic roles in the process of bone formation and
remodeling.
Deficiency in estrogen has been shown to be a risk factor to
induce osteoporosis in postmenopausal women. Recent studies
demonstrated that osteoblasts derived from osteoporotic
patients showed less adhesive ability and lower levels of
integrin/adhesion-mediated signaling activation than the cells
derived from nonosteoporotic patients.
(47) It is possible that the
estrogen-less condition in postmenopausal women may result in
a reduction in mechanical sensitivity of osteoblasts by decreas-
ing the expression of integrins and the activation of integrin/
adhesion-mediated signaling events, which consequently may
influence the formation and remodeling of bone in response to
mechanical stimuli.
In summary, this study demonstrated for the first time that
estrogen augments the shear stress–induced MAPK signaling
and c-fos and Cox-2 expressions in human osteoblast-like MG63
cells and primary osteoblasts. This estrogen-induced augmenta-
tion of signaling and gene expression in response to shear stress
is mediated by ERs through increased expression of b1-integrin.
The identification of this synergistic role of estrogen and shear
stress in modulating signaling and gene expression in
osteoblasic cells not only provides new insights into the
mechanism by which chemical stimuli may influence mechanical
responses of bone cells but also aids in the future development
of bone tissue engineering and pharmacologic therapies to
increase bone formation.
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